CIK: 0001263508 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 16, 2015
Total Value ($000): $10,823,762 (84.3% shares, 15.7% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 19,474,969 | $2,148,673 | 19.9% | $43.21 | +159.5% | COM | 45337C102 |
| — | Seattle Genetics, Inc. | 36,029,746 | $1,389,307 | 12.8% | $34.28 | — | COM | 812578102 |
| — | Alexion Pharmaceuticals, Inc. | 6,542,599 | $1,023,197 | 9.5% | $180.77 | — | COM | 015351109 |
| ABBV | AbbVie Inc. | 14,373,538 | $782,064 | 7.2% | $42.33 | +0.4% | COM | 00287Y109 |
| ACAD | ACADIA Pharmaceuticals Inc. | 20,481,442 | $677,321 | 6.3% | $14.07 | +195.7% | COM | 004225108 |
| — | Incyte Corporation Notes 1.25% 11/15/2020 144A | 274,500,000 | $598,696 | 5.5% | $1.21 | — | CONV BONDS | 45337CAL6 |
| — | Incyte Corporation Notes 0.375% 11/15/2018 144A | 259,000,000 | $559,636 | 5.2% | $1.20 | — | CONV BONDS | 45337CAK8 |
| — | Anacor Pharmaceuticals, Inc. | 4,135,412 | $486,779 | 4.5% | $31.19 | — | COM | 032420101 |
| BMRN | BioMarin Pharmaceutical Inc. | 4,076,353 | $429,321 | 4.0% | $75.89 | +76.0% | COM | 09061G101 |
| — | Genomic Health Inc. | 13,658,328 | $289,011 | 2.7% | $31.71 | — | COM | 37244C101 |
| — | Clovis Oncology Inc. 2.5% 9/15/2021 | 129,300,000 | $215,311 | 2.0% | $1.67 | — | CONV BONDS | 189464AB6 |
| — | DBV Technologies S.A. | 5,462,019 | $194,393 | 1.8% | $32.87 | — | SPONSORED ADR | 23306J101 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 14,110,179 | $160,856 | 1.5% | $7.53 | +77.2% | COM | 09058V103 |
| — | Dyax Corp. | 7,561,480 | $144,349 | 1.3% | $13.14 | — | COM | 26746E103 |
| — | BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | 22,379,000 | $115,619 | 1.1% | $2.76 | — | CONV BONDS | 09061GAD3 |
| — | Mirati Therapeutics, Inc. | 2,955,074 | $101,714 | 0.9% | $18.37 | — | COM | 60468T105 |
| — | Aquinox Pharmaceuticals, Inc. | 6,747,332 | $94,935 | 0.9% | $13.83 | — | COM | 03842B101 |
| — | Gilead, Inc. 1.625% 5/1/16 | 20,944,000 | $90,326 | 0.8% | $2.26 | — | CONV BONDS | 375558AP8 |
| HRTX | Heron Therapeutics, Inc. | 2,907,784 | $70,950 | 0.7% | $13.64 | +144.2% | COM | 427746102 |
| CERS | Cerus Corporation | 13,553,275 | $61,532 | 0.6% | $4.68 | +10.5% | COM | 157085101 |
| — | Bellicum Pharmaceuticals, Inc. | 4,190,594 | $60,889 | 0.6% | $23.04 | — | COM | 079481107 |
| — | Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | 59,583,000 | $54,123 | 0.5% | $1.04 | — | CONV BONDS | 00484MAA4 |
| — | Spark Therapeutics, Inc. | 1,262,382 | $52,679 | 0.5% | $77.50 | — | COM | 84652J103 |
| — | Invitae Corporation | 6,554,967 | $47,327 | 0.4% | $16.76 | — | COM | 46185L103 |
| — | Versartis, Inc. | 3,241,783 | $37,378 | 0.3% | $22.68 | — | COM | 92529L102 |
| — | ImmunoGen, Inc. | 3,548,040 | $34,061 | 0.3% | $11.20 | — | COM | 45253H101 |
| NBIX | Neurocrine Biosciences, Inc. | 750,739 | $29,872 | 0.3% | $25.36 | +90.6% | COM | 64125C109 |
| INSM | Insmed, Inc. | 1,583,490 | $29,405 | 0.3% | $14.99 | +66.6% | COM PAR $.01 | 457669307 |
| — | Acorda Therapeutics, Inc. | 1,096,876 | $29,078 | 0.3% | $34.19 | — | COM | 00484M106 |
| — | Medivation, Inc. | 659,752 | $28,039 | 0.3% | $42.50 | — | COM | 58501N101 |
| HALO | Halozyme Therapeutics, Inc. | 1,931,057 | $25,934 | 0.2% | $6.50 | +209.0% | COM | 40637H109 |
| — | Progenics Pharmaceuticals, Inc. | 4,350,808 | $24,887 | 0.2% | $4.44 | — | COM | 743187106 |
| GILD | Gilead Sciences, Inc. | 249,995 | $24,547 | 0.2% | $36.21 | +114.0% | COM | 375558103 |
| — | Intra-Cellular Therapies, Inc. | 609,166 | $24,391 | 0.2% | $37.28 | — | COM | 46116X101 |
| — | Zogenix, Inc. | 1,798,365 | $24,278 | 0.2% | $13.50 | — | COM NEW | 98978L204 |
| — | Exelisis, Inc. Notes 4.25% 8/15/2019 | 20,000,000 | $23,988 | 0.2% | $1.20 | — | CONV BONDS | 30161QAC8 |
| — | aTyr Pharma Inc. | 2,335,125 | $23,958 | 0.2% | $18.52 | — | COM | 002120103 |
| — | Idera Pharmaceuticals, Inc. | 6,976,162 | $23,370 | 0.2% | $3.05 | — | COM NEW | 45168K306 |
| — | XenoPort, Inc. | 6,508,622 | $22,585 | 0.2% | $5.27 | — | COM | 98411C100 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 7,335,692 | $22,007 | 0.2% | $2.58 | +67.2% | COM | 14888U101 |
| SGMO | Sangamo BioSciences, Inc. | 3,755,876 | $21,183 | 0.2% | $12.49 | -34.0% | COM | 800677106 |
| TGTX | TG Therapeutics, Inc. | 2,003,991 | $20,200 | 0.2% | $4.61 | +223.5% | COM | 88322Q108 |
| — | Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | 26,517,000 | $19,873 | 0.2% | $0.75 | — | CONV BONDS | 00767EAB8 |
| — | Array BioPharma Inc. | 4,310,666 | $19,657 | 0.2% | $6.65 | — | COM | 04269X105 |
| — | Clovis Oncology, Inc. | 202,630 | $18,634 | 0.2% | $56.00 | — | COM | 189464100 |
| — | Alder Biopharmaceuticals Inc. | 513,439 | $16,820 | 0.2% | $27.68 | — | COM | 014339105 |
| — | Derma Sciences, Inc. | 3,457,841 | $16,286 | 0.2% | $12.84 | — | COM PAR $.01 | 249827502 |
| — | BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | 12,228,000 | $15,899 | 0.1% | $1.06 | — | CONV BONDS | 09061GAE1 |
| — | Novavax, Inc. | 2,195,687 | $15,524 | 0.1% | $5.28 | — | COM | 670002104 |
| GLPG | Galapagos NV ADR | 369,276 | $15,033 | 0.1% | $51.50 | — | SPON ADR | 36315X101 |
| — | Foamix Pharmaceuticals Ltd. | 2,046,967 | $15,004 | 0.1% | $7.46 | — | SHS | M46135105 |
| — | Repros Therapeutics Inc. | 1,955,944 | $14,533 | 0.1% | $18.45 | — | COM NEW | 76028H209 |
| PRQR | ProQR Therapeutics N.V. | 988,299 | $14,400 | 0.1% | $17.70 | -5.4% | SHS EURO | N71542109 |
| — | Achillion Pharmaceuticals, Inc. | 2,000,000 | $13,820 | 0.1% | $8.32 | — | COM | 00448Q201 |
| — | Zafgen, Inc. | 390,346 | $12,472 | 0.1% | $35.13 | — | COM | 98885E103 |
| — | bluebird bio, Inc. | 141,105 | $12,072 | 0.1% | $29.38 | — | COM | 09609G100 |
| RARE | Ultragenyx Pharmaceuticals | 123,894 | $11,932 | 0.1% | $51.09 | +124.1% | COM | 90400D108 |
| — | Threshold Pharmaceuticals, Inc. | 2,925,519 | $11,907 | 0.1% | $4.38 | — | COM NEW | 885807206 |
| — | La Jolla Pharmaceutical Company | 412,008 | $11,450 | 0.1% | $10.24 | — | COM PAR $.0001 2 | 503459604 |
| XNCR | Xencor, Inc. | 872,072 | $10,665 | 0.1% | $11.07 | +76.9% | COM | 98401F105 |
| — | Lion Biotechnologies, Inc. | 1,817,429 | $10,468 | 0.1% | $11.31 | — | COM | 53619R102 |
| — | Alcobra Ltd. | 1,639,871 | $9,905 | 0.1% | $5.32 | — | SHS | M2239P109 |
| — | Akari Therapeutics PLC ADR | 395,882 | $9,499 | 0.1% | $23.99 | — | SPONSORED ADR | 00972G108 |
| — | Concert Pharmaceuticals, Inc. | 495,908 | $9,308 | 0.1% | $10.71 | — | COM | 206022105 |
| — | Osiris Therapeutics, Inc. | 499,193 | $9,220 | 0.1% | $16.34 | — | COM | 68827R108 |
| — | Global Blood Therapeutics, Inc. | 200,000 | $8,432 | 0.1% | $42.16 | — | COM | 37890U108 |
| ASND | Ascendis Pharma A/S | 435,540 | $7,709 | 0.1% | $17.62 | — | SPONSORED ADR | 04351P101 |
| MGNX | MacroGenics, Inc. | 347,776 | $7,449 | 0.1% | $23.68 | +32.5% | COM | 556099109 |
| AGIO | Agios Pharmaceuticals, Inc. | 100,000 | $7,059 | 0.1% | $27.47 | +255.8% | COM | 00847X104 |
| — | Dermira, Inc. | 275,000 | $6,419 | 0.1% | $21.44 | — | COM | 24983L104 |
| — | Aimmune Therapeutics, Inc. | 250,000 | $6,330 | 0.1% | $25.32 | — | COM | 00900T107 |
| — | NeuroDerm Ltd. | 305,000 | $6,304 | 0.1% | $15.24 | — | ORD SHS | M74231107 |
| LGND | Ligand Pharmaceuticals Incorporated | 73,386 | $6,286 | 0.1% | $41.68 | +45.6% | COM NEW | 53220K504 |
| — | Endocyte, Inc. | 1,356,552 | $6,213 | 0.1% | $4.58 | — | COM | 29269A102 |
| — | Arrowhead Research Corp. | 1,009,509 | $5,815 | 0.1% | $9.76 | — | COM NEW | 042797209 |
| — | Aerie Pharmaceuticals, Inc. | 299,356 | $5,311 | 0.0% | $17.96 | — | COM | 00771V108 |
| — | Ignyta, Inc. | 571,000 | $5,013 | 0.0% | $8.30 | — | COM | 451731103 |
| — | Trevena, Inc. | 450,000 | $4,658 | 0.0% | $10.35 | — | COM | 89532E109 |
| — | Sage Therapeutics, Inc. | 105,000 | $4,444 | 0.0% | $43.36 | — | COM | 78667J108 |
| — | Chimerix, Inc. | 115,216 | $4,401 | 0.0% | $40.26 | — | COM | 16934W106 |
| — | Amarin Corporation plc | 2,205,710 | $4,257 | 0.0% | $2.34 | — | SPONS ADR NEW | 023111206 |
| — | Pronai Therapeutics, Inc. | 200,000 | $4,104 | 0.0% | $20.52 | — | COM | 74346L101 |
| — | Curis, Inc. | 1,999,303 | $4,039 | 0.0% | $2.72 | — | COM | 231269101 |
| — | Proteon Therapeutics, Inc. | 274,617 | $3,820 | 0.0% | $11.75 | — | COM | 74371L109 |
| — | Seres Therapeutics, Inc. | 125,000 | $3,705 | 0.0% | $41.50 | — | COM | 81750R102 |
| OMER | Omeros Corporation | 336,226 | $3,685 | 0.0% | $12.37 | +25.9% | COM | 682143102 |
| — | Nabriva Therapeutics AG | 350,000 | $3,325 | 0.0% | $9.50 | — | SPONSORED ADR | 62957M104 |
| — | Juno Therapeutics, Inc. | 80,000 | $3,255 | 0.0% | $52.22 | — | COM | 48205A109 |
| — | CytRx Corporation | 1,319,989 | $3,128 | 0.0% | $3.49 | — | COM PAR $.001 | 232828509 |
| — | Epizyme, Inc. | 232,481 | $2,990 | 0.0% | $21.12 | — | COM | 29428V104 |
| — | Stemline Therapeutics, Inc. | 333,497 | $2,945 | 0.0% | $23.84 | — | COM | 85858C107 |
| — | Array BioPharma Inc. Notes 3.0% 6/1/2020 | 3,000,000 | $2,921 | 0.0% | $1.25 | — | CONV BONDS | 04269XAA3 |
| — | Mast Therapeutics, Inc. | 4,707,464 | $2,730 | 0.0% | $0.56 | — | COM | 576314108 |
| ENTA | Enanta Pharmaceuticals, Inc. | 75,357 | $2,723 | 0.0% | $19.50 | +120.2% | COM | 29251M106 |
| NTRA | Natera, Inc. | 250,000 | $2,713 | 0.0% | $16.90 | 0.0% | COM | 632307104 |
| — | Sunesis Pharmaceuticals, Inc. | 3,200,000 | $2,592 | 0.0% | $2.55 | — | COM NEW | 867328601 |
| — | Affimed N.V. | 400,000 | $2,468 | 0.0% | $6.30 | — | COM | N01045108 |
| — | Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | 3,423,000 | $2,450 | 0.0% | $0.76 | — | CONV BONDS | 74365AAB7 |
| — | Assembly Biosciences, Inc. | 250,000 | $2,390 | 0.0% | $13.24 | — | COM | 045396108 |
| — | Isis Pharmaceuticals, Inc. | 57,140 | $2,310 | 0.0% | $26.87 | — | COM | 464330109 |
| — | Karyopharm Therapeutics Inc. | 216,990 | $2,285 | 0.0% | $31.09 | — | COM | 48576U106 |
| — | Vitae Pharmaceuticals, Inc. | 187,597 | $2,065 | 0.0% | $11.71 | — | COM | 92847N103 |
| AUPH | Aurinia Pharmaceuticals Inc. | 711,499 | $1,999 | 0.0% | $3.55 | -3.5% | COM | 05156V102 |
| — | Dynavax Technologies Corporation | 75,000 | $1,841 | 0.0% | $24.55 | — | COM NEW | 268158201 |
| — | Bellerophon Therapeutics, Inc. | 352,928 | $1,832 | 0.0% | $9.18 | — | COM | 078771102 |
| — | Immune Design Corp. | 148,937 | $1,817 | 0.0% | $20.65 | — | COM | 45252L103 |
| IRWD | Ironwood Pharmaceuticals, Inc. | 169,163 | $1,763 | 0.0% | $11.63 | -19.8% | COM CL A | 46333X108 |
| — | Loxo Oncology, Inc. | 100,000 | $1,748 | 0.0% | $13.13 | — | COM | 548862101 |
| — | MediWound Ltd. | 225,000 | $1,717 | 0.0% | $11.38 | — | ORD SHS | M68830104 |
| — | Marinus Pharmaceuticals, Inc. | 200,000 | $1,668 | 0.0% | $6.47 | — | COM | 56854Q101 |
| — | Palatin Technologies, Inc. | 2,050,000 | $1,661 | 0.0% | $0.73 | — | COM PAR $ .01 | 696077403 |
| — | Ophthotech Corporation | 35,649 | $1,444 | 0.0% | $32.35 | — | COM | 683745103 |
| CLLS | Cellectis S.A. | 50,000 | $1,318 | 0.0% | $34.58 | — | SPONSORED ADS | 15117K103 |
| — | Tenax Therapeutics Inc. | 420,000 | $1,260 | 0.0% | $3.58 | — | COM | 88032L100 |
| ADAPY | Adaptimmune Therapeutics plc ADR | 100,000 | $1,197 | 0.0% | $18.33 | — | SPONDS ADR | 00653A107 |
| — | BioDelivery Sciences International, Inc. | 210,021 | $1,168 | 0.0% | $5.21 | — | COM | 09060J106 |
| ABUS | Arbutus Biopharma Corporation | 180,582 | $1,100 | 0.0% | $8.87 | 0.0% | COM | 03879J100 |
| — | Discovery Laboratories, Inc. | 3,569,643 | $1,071 | 0.0% | $1.95 | — | COM NEW | 254668403 |
| — | Ohr Pharmaceuticals, Inc. | 370,370 | $1,022 | 0.0% | $2.54 | — | COM NEW | 67778H200 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11,340 | $911 | 0.0% | $77.42 | +43.5% | COM | 02043Q107 |
| ALDX | Aldeyra Therapeutics, Inc. | 142,000 | $828 | 0.0% | $10.20 | -23.5% | COM | 01438T106 |
| — | Trillium Therapeutics, Inc. | 63,014 | $821 | 0.0% | $13.03 | — | COM NEW | 89620X506 |
| — | Ritter Pharmaceuticals, Inc. | 400,000 | $820 | 0.0% | $4.45 | — | COM | 767836109 |
| — | Acceleron Pharma, Inc. | 28,765 | $716 | 0.0% | $39.60 | — | COM | 00434H108 |
| QURE | UniQure B.V. | 30,000 | $614 | 0.0% | $15.95 | +65.1% | SHS | N90064101 |
| — | Achaogen, Inc. | 100,000 | $576 | 0.0% | $15.46 | — | COM | 004449104 |
| — | Foundation Medicine, Inc. | 20,892 | $385 | 0.0% | $25.16 | — | COM | 350465100 |
| — | Synergy Pharmaceuticals, Inc. | 67,100 | $356 | 0.0% | $5.31 | — | COM NEW | 871639308 |
| — | ChemoCentryx, Inc. | 49,064 | $297 | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Five Prime Therapeutics, Inc. | 19,247 | $296 | 0.0% | $16.80 | — | COM | 33830X104 |
| — | Aptose Biosciences, Inc. | 33,397 | $144 | 0.0% | $5.91 | — | COM NEW | 03835T200 |
| — | Cyclacel Pharmaceuticals, Inc. Pfd. Conv. Ex 6% | 13,253 | $62 | 0.0% | $7.20 | — | PFD CONV EX 6% | 23254L207 |
| — | BioTime, Inc. Rights | 20,084 | $17 | 0.0% | $1.07 | — | *W EXP 10/01/201 | 09066L162 |